Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02484898 · ClinicalTrials.gov registry record
SEEQ™ Performance Study
A clinical trial of Arrhythmia Type Unknown, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- 200
- Enrollment target
- 9
- Study locations
NCT02484898 is a study of Arrhythmia Type Unknown that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 200 participants. The trial reports 9 study locations across 6 states.
The verdict
NCT02484898, a study of Arrhythmia Type Unknown, has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
- 9
- Study locations
Study Summary
The purpose of the Medtronic SEEQ™ Performance study is to build further evidence on the clinical and economic benefit of the Medtronic market-released SEEQ™ Mobile Cardiac Telemetry System/External Cardiac Monitor System (MCT/ECM).
Conditions Studied
Study Locations (9)
Florida
- - Clearwater
- - Palm Beach Gardens
- - Sebring
California
- - Larkspur
- - Simi Valley
Colorado
- - Aurora
Georgia
- - Rome
Mississippi
- - Jackson
Nevada
- - Henderson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2015-06 |
| Est. Completion | 2016-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02484898
The ClinicalTrials.gov registry entry for NCT02484898 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Arrhythmia Type Unknown appearing as the primary indexed condition, and to 0 interventions.
NCT02484898 reports 9 study locations spanning 6 distinct geographic areas - top geographies include Florida, California, Colorado.
Frequently Asked Questions
What is clinical trial NCT02484898 about?
NCT02484898 is a clinical study titled "SEEQ™ Performance Study". The purpose of the Medtronic SEEQ™ Performance study is to build further evidence on the clinical and economic benefit of the Medtronic market-released SEEQ™ Mobile Cardiac Telemetry System/External Cardiac Monitor System (MCT/ECM).
What is the current status of trial NCT02484898?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2015-06. Estimated completion is 2016-08.
What conditions does trial NCT02484898 study?
This clinical trial studies the following conditions: Arrhythmia Type Unknown.
Who is sponsoring clinical trial NCT02484898?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02484898 being conducted?
This trial has 9 study locations across California, Colorado, Florida, Georgia, Mississippi. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.